期刊文献+

登革热Ⅳ型病毒在地鼠肾细胞培养内减毒的研究 被引量:3

Study of Attenuation of Dengue Type 4 Virus by Consecutive Passages in Primary Hamster Kidney Tissue Culture
原文传递
导出
摘要 本文报道登革热Ⅳ型病毒Ban18株通过原代地鼠肾细胞连续传代后的适应和减毒过程。 Ban18原株对原代地鼠肾细胞无病变或仅有极轻微病变,对乳小白鼠及断乳鼠的脑内毒力高达LD_(50)为Log6—7。通过连续传20—70代后,病变逐渐加重,出现时间缩短,二天即可达到细胞完全破坏。培养液内的病毒含量也随之提高达10~6—10~7/ml TCID_(50)。但随着传代代数增加,病毒对乳小白鼠的嗜神经毒力逐渐降低,脑内接种后仅个别发病或完全不致死。脑组织病理变化也较原株明显减轻,接种树鼩不产生病毒血症。以上结果符合弱毒株的减毒指标,是一株有希望的活疫苗毒株。 A dengue type 4 virus Ban18 strain, isolated from non-epidemic area in China, was chosen for attenuation by consecutive passages in primary hamster kidney tissue culture(PHKTC). During the course of passage from 20 to 70, the CPE in PHKTC became more and more apparent and a high virus titer up to 10~6-10~7 TCID_(50) per ml could be reached. Meanwhile the neurovirulence to suckling mice was gradually reduced from 10~6-10~7LD_(50)/ml for the parental virus to no death or only individual death of animal for the attenuated Viruses. This attenuated strain was preliminarily considered to be a candidate virus strain for production of live vaccine.
出处 《病毒学杂志》 CSCD 1989年第1期38-44,共7页
关键词 登革热Ⅳ型病毒 地鼠肾细胞减毒 Deugue type Ⅳ virus Attenuation in primary hamster kindney cell culture
  • 相关文献

同被引文献24

  • 1刘志文,俞永新,王志伟,刘文雪,贾丽丽,董关木.登革4型病毒Ban18-30减毒株的生物学特性研究[J].国际流行病学传染病学杂志,2006,33(3):145-149. 被引量:1
  • 2张海林 自登云 等.从云南白纹伊蚊分得登革热Ⅳ型病毒[J].中华流行病学杂志,1984,5(4):251-251.
  • 3Kanesa-thasan N,Sun W,Kim-Ahn G,et al.Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.Vaccine,2001,19(23-24):3179-3188.
  • 4Rothman AL,Kanesa-thasan N,West K,et al.Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine.Vaccine,2001,19(32):4694-4699.
  • 5Sabchareon A,Lang J,Chanthavanich P,et al.Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five-to twelve-year-old Thai children.Pediatr Infect Dis J,2004,23(2):99-109.
  • 6Edelman R,Wasserman SS,Bodison SA,et al.Phase Ⅰ trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.Am J Trop Med Hyg,2003,69(6 Suppl):48-60.
  • 7Chambers TJ,Liang Y,Droll DA,et al.Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras:biological characterization,immunogenicity,and protection against dengue encephalitis in the mouse model.J Virol,2003,77(6):3655-3668.
  • 8Rey FA, Heinz FX, Mandl C, et al. The envelope glycoprotein from tick-borne encephalitis virus at 2 resolution [J]. Nature, 1995, 375(6529) :291-298.
  • 9Kawano H, Rostapshov V, Rosen L, et al. Genetic determinants of dengue type 4 virus neurovirulence for mice[J]. J Virol, 1993, 67(11) :6567-6575.
  • 10Zhao B, Mackow E, Buckler-White A, et al. Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins[J]. Virology, 1986, 155(1):77-88.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部